World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
17772
World Ranking
2579
National Ranking
1230

Yair Reisner publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yair Reisner sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 300 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yair Reisner D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yair Reisner sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yair Reisner is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research spans multiple disciplines within medicine, with significant contributions in immunology, surgery, pulmonary and respiratory medicine, molecular biology, and genetics.

The focus of Reisner's research includes topics such as transplantation methods and outcomes, T-cell and B-cell immunology, CAR-T cell therapy research, neonatal respiratory health research, immunotherapy and immune responses, immune cell function and interaction, and chromatin remodeling and cancer.

Selected recent papers authored or co-authored by Yair Reisner highlight this multidisciplinary approach and include:

  • Multi-lineage Lung Regeneration by Stem Cell Transplantation across Major Genetic Barriers, 2020, published in Cell Reports
  • Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors, 2021, published in Journal for ImmunoTherapy of Cancer
  • Lung cell transplantation for pulmonary fibrosis, 2024, published in Science Advances
  • Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors, 2021, published in bioRxiv (Cold Spring Harbor Laboratory)
  • Lung Regeneration by Transplantation of Allogeneic Lung Progenitors Using a Safer Conditioning Regimen and Clinical-grade Reagents, 2022, published in Stem Cells Translational Medicine

Frequent co-authors collaborating with Reisner include Esther Bachar Lustig, Chava Rosen, Sandeep Kumar Yadav, Einav Shoshan, and Richard E. Champlin, reflecting ongoing partnerships in advancing research in transplantation and immunology.

Publication venues where Reisner has contributed multiple papers are:

  • Stem Cells Translational Medicine (3 publications)
  • Blood (3 publications)
  • Cell Reports (2 publications)
  • bioRxiv (Cold Spring Harbor Laboratory) (2 publications)
  • American Journal of Respiratory Cell and Molecular Biology (2 publications)

Their main fields of study reflect a strong orientation toward medicine and immunology and microbiology, with 29 and 12 publications respectively in these areas. Subfields include immunology, surgery, pulmonary and respiratory medicine, molecular biology, and genetics.

Best Publications

  • Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.

    Aversa F;Tabilio A;Velardi A;Cunningham I

  • Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

    Mauro Di Ianni;Mauro Di Ianni;Franca Falzetti;Alessandra Carotti;Adelmo Terenzi

  • Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of Relapse

    Franco Aversa;Adelmo Terenzi;Antonio Tabilio;Franca Falzetti

  • Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin.

    Yair Reisner;Mariana Linker-Israeli;Nathan Sharon

  • Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

    Y Reisner;N Kapoor;D Kirkpatrick;Pollack

  • Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

    Yair Reisner;Dahlia Kirkpatrick;Bo Dupont;Neena Kapoor

  • Human Embryonic Stem Cells and Their Differentiated Derivatives Are Less Susceptible to Immune Rejection Than Adult Cells

    Micha Drukker;Helena Katchman;Gil Katz;Smadar Even Tov Friedman

  • Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

    Esther Bachar-Lustig;Nurit Rachamim;Hong-Wei Li;Fenshou Lan

  • HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse

    Massimo Fabrizio Martelli;Mauro Di Ianni;Mauro Di Ianni;Loredana Ruggeri;Franca Falzetti

  • Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells

    Lior Zangi;Raanan Margalit;Shlomit Reich-Zeliger;Esther Bachar-Lustig

  • Human and porcine early kidney precursors as a new source for transplantation

    Benjamin Dekel;Tatyana Burakova;Fabian D. Arditti;Shlomit Reich-Zeliger

  • Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins.

    Yair Reisner;Lea Itzicovitch;Asher Meshorer;Nathan Sharon

  • Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

    Nurit Rachamim;Judith Gan;Harry Segall;Rita Krauthgamer

  • Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells

    Yair Reisner;Massimo F. Martelli

  • Bone Marrow Transplantation after the Chernobyl Nuclear Accident

    Alexandr Baranov;Robert Peter Gale;Angelina Guskova;Evgeny Piatkin

  • Haploidentical hematopoietic transplantation: current status and future perspectives.

    Yair Reisner;David Hagin;Massimo F. Martelli

  • Isolation and Characterization of Nontubular Sca-1+Lin− Multipotent Stem/Progenitor Cells from Adult Mouse Kidney

    Benjamin Dekel;Lior Zangi;Elias Shezen;Shlomit Reich-Zeliger

  • The hepatitis B virus–trimera mouse: A model for human HBV infection and evaluation of anti-HBV therapeutic agents

    Ehud Ilan;Tatjana Burakova;Shlomo Dagan;Ofer Nussbaum

  • Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells.

    Yair Reisner;Miriam Biniaminov;Esther Rosenthal;Nathan Sharon

  • Interaction of peanut agglutinin, a lectin specific for nonreducing terminal d-galactosyl residues, with embryonal carcinoma cells

    Yaīr Reisner;Gabriel Gachelin;Philippe Dubois;Jean-François Nicolas

  • Graft rejection and graft-versus-host disease: mirror images.

    Robert Peter Gale;Robert Peter Gale;Yair Reisner;Yair Reisner

Frequent Co-Authors

Massimo F. Martelli
Massimo F. Martelli University of Perugia
Antonio Tabilio
Antonio Tabilio University of L'Aquila
Nathan Sharon
Nathan Sharon Weizmann Institute of Science
Andrea Velardi
Andrea Velardi University of Perugia
Daniel Shouval
Daniel Shouval Hebrew University of Jerusalem
Tsvee Lapidot
Tsvee Lapidot Weizmann Institute of Science
Robert A. Good
Robert A. Good University of Minnesota
Arnon Nagler
Arnon Nagler Sheba Medical Center
Gideon Rechavi
Gideon Rechavi Sheba Medical Center
Robert S. Negrin
Robert S. Negrin Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in combining Immunology with healthcare, pursuing an accelerated path in nursing can be a great option. Many students explore an accelerated nurse practitioner program to quickly enter the workforce with advanced skills relevant to immunological care and patient management.

Transitioning within nursing specialties is also common, particularly for those aiming to work in critical care environments where immunology knowledge is key. Certification programs like acute care np certification can enable Family Nurse Practitioners to specialize and better support patients with complex immunological disorders.

If you’re starting from scratch, enrolling in online RN programs for non nurses in Florida offers flexible pathways to enter the nursing profession without previous experience, paving the way to advanced roles that intersect with Immunology. These programs often provide the foundational clinical knowledge needed for immunology-related careers.

For a smoother entry into the field, researching the easiest absn programs to get into can help prospective students find accessible Bachelor of Science in Nursing options, thereby opening doors to specialized graduate studies and careers focused on Immunology.

Best Scientists Citing Yair Reisner

Trending Scientists

Recently Published Articles